更多
通知
医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
更多
在国内外文献保障系统中检索
高级检索 检索偏好
热搜词：
换一批
  • 二次检索
  • 检索历史
论文 期刊
取消
高级检索

检索历史 清除

首页> Signal transduction and targeted therapy> Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study.

Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study.

导出 LinkOut
翻译 打印 收藏 分享
  • 新浪微博
  • 微信
  • QQ空间
  • 豆瓣
 纠错
广告
第一作者： Yan,Gao
第一单位： State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.;Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
作者： Yan,Gao [1] ; Haixia,He [2] ; Xueping,Li [3] ; Liling,Zhang [4] ; Wei,Xu [5] ; Ru,Feng [6] ; Wenyu,Li [7] ; Yin,Xiao [4] ; Xinxiu,Liu [4] ; Yu,Chen [8] ; Xiaoxiao,Wang [1] ; Bing,Bai [1] ; Huijing,Wu [9] ; Qingqing,Cai [1] ; Zhiming,Li [1] ; Jibin,Li [10] ; Suxia,Lin [11] ; Yanxia,He [1] ; Liqin,Ping [1] ; Cheng,Huang [1] ; Jiaying,Mao [1] ; Xiujin,Chen [1] ; Baitian,Zhao [10] ; Huiqiang,Huang [12]
作者单位： State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.;Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. [1] Department of Radiation Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. [2] Department of Hematology, Sun Yat-sen University Cancer Center, Guangzhou, China. [3] Cancer Center, Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China. [4] Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China. [5] Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China. [6] Department of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China. [7] Department of pathology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China. [8] Department of Medical Oncology, Hubei Cancer Center, Wuhan, China. [9] Department of Clinical Research, Sun Yat-sen University Cancer Center, Guanzhou, China. [10] Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China. [11] State Key Laboratory of Oncology in South China & Collaborative Innovation Center of Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China. huanghq@sysucc.org.cn.;Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. huanghq@sysucc.org.cn. [12]
医学主题词 人类(Humans);男(雄)性(Male);女(雌)性(Female);中年人(Middle Aged);苯甲酰胺类(Benzamides);老年人(Aged);淋巴瘤, 结外NK-T细胞(Lymphoma, Extranodal NK-T-Cell);组蛋白脱乙酰基酶抑制剂(Histone Deacetylase Inhibitors);成年人(Adult);氨基吡啶类(Aminopyridines);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols)
DOI 10.1038/s41392-024-01825-0
PMID 38755119
发布时间 2025-07-24
提交
  • 浏览4
Signal transduction and targeted therapy

Signal transduction and targeted therapy

2024年9卷1期

121页

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中！

加载中！

加载中！

加载中！

  • 浏览4
Signal transduction and targeted therapy 点击下载 本期目录封面

Signal transduction and targeted therapy

2024年9卷1期

121页

相关期刊

加载中！

法律状态公告日 法律状态 法律状态信息

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

  • 客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)

  • |

  • 客服邮箱：yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷